Detection of p53 mutations in sputum smears precedes diagnosis of non-small cell lung carcinoma

Jung T A Chen, William L. Ho, Ya Wen Cheng, Huei Lee

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Little progress has been made in reducing lung cancer mortality by applying conventional methods to early diagnosis and screening. Recent advances in molecular oncology, however, have provided tools which may be of use in this area. p53 gene mutation is the most common gene alteration in the development of lung cancer. Conventional cytologic analysis of sputum is an insensitive test for the diagnosis of lung cancer. In this study, we attempted to establish a polymerase chain reaction (PCR)-based assay for assessing the possibility of early detection of p53 mutation in archival Papanicolaou-stained cytologic sputum smears. Ten sputum smear slides were collected prior to clinical diagnosis from 10 lung cancer patients who had been confirmed to have p53 mutations in surgically resected lung tumors. We successfully obtained sufficient amounts of RNA from each sputum smear specimen for amplification of PCR and direct sequencing. Only one patient was found to have p53 mutation at codon 286; the other nine patients had wild type p53 genes. This result supports the possibility that detection of p53 mutations in cytologic sputum smears is an available strategy for the early diagnosis of lung cancer.

Original languageEnglish
Pages (from-to)2687-2690
Number of pages4
JournalAnticancer Research
Volume20
Issue number4
Publication statusPublished - 2000
Externally publishedYes

Fingerprint

Sputum
Non-Small Cell Lung Carcinoma
Lung Neoplasms
Mutation
p53 Genes
Polymerase Chain Reaction
Early Detection of Cancer
Codon
Early Diagnosis
RNA
Lung
Mortality
Genes
Neoplasms

Keywords

  • NSCLC
  • p53 mutation
  • Sputum smears

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Chen, J. T. A., Ho, W. L., Cheng, Y. W., & Lee, H. (2000). Detection of p53 mutations in sputum smears precedes diagnosis of non-small cell lung carcinoma. Anticancer Research, 20(4), 2687-2690.

Detection of p53 mutations in sputum smears precedes diagnosis of non-small cell lung carcinoma. / Chen, Jung T A; Ho, William L.; Cheng, Ya Wen; Lee, Huei.

In: Anticancer Research, Vol. 20, No. 4, 2000, p. 2687-2690.

Research output: Contribution to journalArticle

Chen, JTA, Ho, WL, Cheng, YW & Lee, H 2000, 'Detection of p53 mutations in sputum smears precedes diagnosis of non-small cell lung carcinoma', Anticancer Research, vol. 20, no. 4, pp. 2687-2690.
Chen, Jung T A ; Ho, William L. ; Cheng, Ya Wen ; Lee, Huei. / Detection of p53 mutations in sputum smears precedes diagnosis of non-small cell lung carcinoma. In: Anticancer Research. 2000 ; Vol. 20, No. 4. pp. 2687-2690.
@article{01a52e90baff41949a9f15f62ea66283,
title = "Detection of p53 mutations in sputum smears precedes diagnosis of non-small cell lung carcinoma",
abstract = "Little progress has been made in reducing lung cancer mortality by applying conventional methods to early diagnosis and screening. Recent advances in molecular oncology, however, have provided tools which may be of use in this area. p53 gene mutation is the most common gene alteration in the development of lung cancer. Conventional cytologic analysis of sputum is an insensitive test for the diagnosis of lung cancer. In this study, we attempted to establish a polymerase chain reaction (PCR)-based assay for assessing the possibility of early detection of p53 mutation in archival Papanicolaou-stained cytologic sputum smears. Ten sputum smear slides were collected prior to clinical diagnosis from 10 lung cancer patients who had been confirmed to have p53 mutations in surgically resected lung tumors. We successfully obtained sufficient amounts of RNA from each sputum smear specimen for amplification of PCR and direct sequencing. Only one patient was found to have p53 mutation at codon 286; the other nine patients had wild type p53 genes. This result supports the possibility that detection of p53 mutations in cytologic sputum smears is an available strategy for the early diagnosis of lung cancer.",
keywords = "NSCLC, p53 mutation, Sputum smears",
author = "Chen, {Jung T A} and Ho, {William L.} and Cheng, {Ya Wen} and Huei Lee",
year = "2000",
language = "English",
volume = "20",
pages = "2687--2690",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "4",

}

TY - JOUR

T1 - Detection of p53 mutations in sputum smears precedes diagnosis of non-small cell lung carcinoma

AU - Chen, Jung T A

AU - Ho, William L.

AU - Cheng, Ya Wen

AU - Lee, Huei

PY - 2000

Y1 - 2000

N2 - Little progress has been made in reducing lung cancer mortality by applying conventional methods to early diagnosis and screening. Recent advances in molecular oncology, however, have provided tools which may be of use in this area. p53 gene mutation is the most common gene alteration in the development of lung cancer. Conventional cytologic analysis of sputum is an insensitive test for the diagnosis of lung cancer. In this study, we attempted to establish a polymerase chain reaction (PCR)-based assay for assessing the possibility of early detection of p53 mutation in archival Papanicolaou-stained cytologic sputum smears. Ten sputum smear slides were collected prior to clinical diagnosis from 10 lung cancer patients who had been confirmed to have p53 mutations in surgically resected lung tumors. We successfully obtained sufficient amounts of RNA from each sputum smear specimen for amplification of PCR and direct sequencing. Only one patient was found to have p53 mutation at codon 286; the other nine patients had wild type p53 genes. This result supports the possibility that detection of p53 mutations in cytologic sputum smears is an available strategy for the early diagnosis of lung cancer.

AB - Little progress has been made in reducing lung cancer mortality by applying conventional methods to early diagnosis and screening. Recent advances in molecular oncology, however, have provided tools which may be of use in this area. p53 gene mutation is the most common gene alteration in the development of lung cancer. Conventional cytologic analysis of sputum is an insensitive test for the diagnosis of lung cancer. In this study, we attempted to establish a polymerase chain reaction (PCR)-based assay for assessing the possibility of early detection of p53 mutation in archival Papanicolaou-stained cytologic sputum smears. Ten sputum smear slides were collected prior to clinical diagnosis from 10 lung cancer patients who had been confirmed to have p53 mutations in surgically resected lung tumors. We successfully obtained sufficient amounts of RNA from each sputum smear specimen for amplification of PCR and direct sequencing. Only one patient was found to have p53 mutation at codon 286; the other nine patients had wild type p53 genes. This result supports the possibility that detection of p53 mutations in cytologic sputum smears is an available strategy for the early diagnosis of lung cancer.

KW - NSCLC

KW - p53 mutation

KW - Sputum smears

UR - http://www.scopus.com/inward/record.url?scp=0033860898&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033860898&partnerID=8YFLogxK

M3 - Article

C2 - 10953344

AN - SCOPUS:0033860898

VL - 20

SP - 2687

EP - 2690

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 4

ER -